Takeda, U.K. college explore stem cell therapy for muscular dystrophy

03/10/2014 | Genetic Engineering & Biotechnology News

Takeda will work with University College London to study the potential of induced pluripotent stem cells in the treatment of patients with muscular dystrophy. The $250,000 fund from Takeda's New Frontier Science group will also be used to explore new muscular dystrophy treatments through gene and cell therapy techniques using novel biomaterials and artificial human chromosomes.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL